Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Emerge Weight Loss vs OlleveCare

Emerge Weight Loss
Graded #447

Higher grade

vs+8.899999999999999
OlleveCare
Graded #497

Lower grade

The verdict

Emerge Weight Loss takes it — 55.1/100 to 46.2/100.

Emerge Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Emerge Weight Loss is a nationwide telehealth platform focused specifically on compounded tirzepatide for medical weight management.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOlleveCare +9
36
45
Dose & formulationEmerge Weight Loss +2
42
40
Clinical oversightEmerge Weight Loss +31
84
53
Labs & monitoringEmerge Weight Loss +5
54
49
FulfillmentEmerge Weight Loss +32
70
38
Contract termsEven
55
55
Emerge Weight Loss · left barOlleveCare · right bar

The numbers

MetricEmerge Weight LossOlleveCare
WeighScore55.1/10046.2/100
GradeCC
Scorecard rank#447#497
SemaglutideNot disclosedNot disclosed
Tirzepatide$287/mo (2.5 mg dose, compounded)Not disclosed
CoverageCoverage not published13 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Emerge Weight Loss

Graded #447 · C

Strengths

  • Tirzepatide-focused (largest effect-size compounded GLP-1)
  • Wide dose range available
  • Physician-supervised telemedicine model

Where it loses points

  • Semaglutide is available only on request — the site and default plans are tirzepatide-only
  • Less brand recognition than Henry Meds, Mochi, or SkinnyRx
OlleveCare

Graded #497 · C

Strengths

  • 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
  • Both semaglutide and tirzepatide offered — switch molecules without switching platforms
  • Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
  • Cash-pay with a superbill option for out-of-network reimbursement
  • Founder Ahmed Emam is named in the footer

Where it loses points

  • Legal entity name not disclosed anywhere — can't be verified in a state registry
  • Pricing not shown before booking — you must enter the intake flow to see the fee
  • Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
  • No medical director or prescribing clinician named — only 'board-certified providers'
  • No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard